Advair diskus Teaching 43
Instructed in new medication Advair diskus to manage asthma. In addition, warned of possible S/E such as sleep disorders, tremor, hypnagogic effects, compressed nerve syndromes, headache, pain, palpitations, pharyngitis, sinusitis, hoarseness (or dysphonia), rhinorrhea, rhinitis, sneezing, nasal irritation, blood in nasal mucosa, keratitis, conjunctivitis, eye redness, viral eye infections, congestion, nausea, vomiting, abdominal pain and discomfort, diarrhea, gastroenteritis, oral discomfort and pain, constipation, oral ulcerations, oral erythema and rashes, oral candidiasis, appendicitis, dental discomfort and pain, unusual taste, muscular pain, arthralgia, articular rheumatism, muscle stiffness, tightness, rigidity, bone and cartilage disorders, upper respiratory tract infection, upper respiratory tract inflammation, lower respiratory tract viral infection, bronchitis, cough, pneumonia, urticaria, flakiness, disorders of sweat and sebum, sweating, hives, viral infections, chest symptoms, fluid retention, bacterial infections, allergic reactions.
Reviewed November 2017
Reviewed for general reference only. Adapt to your patient, agency policy, and scope of practice.
Related teachings
Advair diskus Teaching 2064SN instructed patient / caregiver that Advair Diskus is a combination of inhaled drugs that is used to treat asthma and chronic bronchitis. SN instructed patient / caregiver on common side effects including upper respira...Advair diskus Teaching 1950SN instructed patient / caregiver that the combination preparation fluticasone/salmeterol (Advair diskus) is a formulation containing fluticasone propionate and salmeterol xinafoate, used in the management of asthma and...